C57BL/6JGpt-Ptf1aem1Cin(P2A-CreERT2)/Gpt
Mouse Model: Ptf1a-P2A-CreERT2
Strain Number: T006208
Knockin (KI)
- Product Type:
- Quantity: - +
- Sex:
- Age:
- Genotype:
GemPharmatech Offers the World’s Largest Knockout and Conditional Knockout Library
With over 25,000 mouse models available and thousands of new strains developed annually, GemPharmatech has built the world’s largest knockout and conditional knockout resource library. Every model is generated using cutting-edge gene editing and validated at the genomic level to ensure reliability. Choosing GemPharmatech means more than acquiring a mouse model, it means partnering with a global leader committed to scientific rigor, competitive pricing, and timely delivery of the mice models your research requires.
| Strain Name: | C57BL/6JGpt-Ptf1aem1Cin(P2A-CreERT2)/Gpt |
| Strain Number: | T006208 |
| Official Symbol: | Ptf1a,CreERT2 |
| Strain Strategy: | T006208.Ptf1a-P2A-CreERT2 Cas9-KI Strategy-EN.pdfT006208.Ptf1a-P2A-CreERT2 strain info.pdf |
| Official Full Name: | pancreas specific transcription factor, 1a |
| Also Known As: | PTF1-p48,PTF1p48,bHLHa29 |
| NCBI Number: | 19213 |
| MGI Number: | 1328312 |
| Chromosome: | 2 |
| Research Areas: | Tool Mice,Cre/Dre |
| Strain Background: | [N000013] C57BL/6JGpt |
| Modification Type: | Knockin (KI) |
| Genotyping Protocols: | T006208.Ptf1a-CreERT2 Genotyping Protocol(KI).pdf |
| Inventory Status: | Cryopreserved |
| Sale Status: | IF (Available for Distribution) |
| Health Status: | Specific pathogen free (SPF) |
| Publications: | 1. ATP citrate lyase ablation hampers exocrine regeneration via TLR4/NF-kappaB signaling after acute pancreatitis in mice. Int Immunopharmacol (2024) |
| Gene Family: | Basic helix-loop-helix proteinsPTF1 complex |
Extend the Value of Your Mouse Models with Integrated Preclinical Services
GemPharmatech not only provides access to advanced genetically engineered mouse models but also offers comprehensive preclinical research services to help you maximize their value. Our scientific team can support your studies from model construction through phenotype validation and pharmacology testing, ensuring that every experiment is designed for translational relevance. By pairing this conditional knockout model with GemPharmatech’s preclinical services, you gain an integrated workflow that accelerates discovery, reduces risk, and produces robust, actionable data.